19.3.8 PHARMACEUTICAL CORPORATIONS’ SECRET KICKBACKS TO PHARMACIES

WHEREAS It has been documented via hidden camera investigation and confidential documents obtained by CBC’s The Fifth Estate that Canada’s largest pharmaceutical distributor is profiting from illegal kickbacks on sales of generic drugs in Ontario, which is driving up the cost of drugs across Canada, and

WHEREAS It is critical for Canadian citizens to have affordable access to prescription drugs, and

WHEREAS The Canadian federal government regulates the price of patented drugs in Canada, while the prices of generic drugs are set by the provinces and territories.

THEREFORE BE IT RESOLVED That the National Pensioners Federation (NPF) follow up on the letter regarding pharmacy drug sales kickbacks that it sent on March 21, 2019 to the Honourable Ginette Petitpas Taylor, Minister of Health, and the response letter to the NPF from the Strategic Policy Branch Health Canada, to ensure that the federal government continues to work with the provinces and territories as an active member of the pan-Canadian Pharmaceutical Alliance (pCPA) to combine the governments’ collective buying power to set the price point for many generic drugs as well as to negotiate lower prices on brand names for all public plans, and

BE IT FURTHER RESOLVED That the NPF’s message to the federal government should continue to be that the governments should be doing all that they can to prevent pharmacy drug sales kickbacks.

Submitted by British Columbia Federation of Retired Union Members